Succinate Dehydrogenase-Deficient GISTs: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 66 Gastric GISTs With Predilection to Young Age
暂无分享,去创建一个
[1] R. Casadio,et al. SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing. , 2011, Journal of the National Cancer Institute.
[2] M. Heinrich,et al. “Pediatric-type” Gastrointestinal Stromal Tumors in Adults: Distinctive Histology Predicts Genotype and Clinical Behavior , 2011, The American journal of surgical pathology.
[3] J. Lasota,et al. Succinate Dehydrogenase Subunit B (SDHB) Is Expressed in Neurofibromatosis 1-Associated Gastrointestinal Stromal Tumors (Gists): Implications for the SDHB Expression Based Classification of Gists , 2011, Journal of Cancer.
[4] C. Antonescu,et al. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations , 2010, Proceedings of the National Academy of Sciences.
[5] P. Bénit,et al. SDHA is a tumor suppressor gene causing paraganglioma. , 2010, Human molecular genetics.
[6] H. Morreau,et al. Low penetrance of a SDHB mutation in a large Dutch paraganglioma family , 2010, BMC Medical Genetics.
[7] A. Chou,et al. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. , 2010, Human pathology.
[8] D. Winge,et al. Succinate dehydrogenase - Assembly, regulation and role in human disease. , 2010, Mitochondrion.
[9] A. Chou,et al. Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types , 2010, The American journal of surgical pathology.
[10] W. Young,et al. Gastric Stromal Tumors in Carney Triad Are Different Clinically, Pathologically, and Behaviorally From Sporadic Gastric Gastrointestinal Stromal Tumors: Findings in 104 Cases , 2010, The American journal of surgical pathology.
[11] J. Carney,et al. Carney triad: a syndrome featuring paraganglionic, adrenocortical, and possibly other endocrine tumors. , 2009, The Journal of clinical endocrinology and metabolism.
[12] E. van Marck,et al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. , 2009, The Lancet. Oncology.
[13] A. Vénisse,et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. , 2009, The Journal of clinical endocrinology and metabolism.
[14] J. Carney,et al. The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney–Stratakis syndrome): molecular genetics and clinical implications , 2009, Journal of internal medicine.
[15] C. Stratakis,et al. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma–paraganglioma syndromes , 2009, Journal of internal medicine.
[16] Narasimhan P. Agaram,et al. Novel V600E BRAF mutations in imatinib‐naive and imatinib‐resistant gastrointestinal stromal tumors , 2008, Genes, chromosomes & cancer.
[17] J. Lasota,et al. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours , 2008, Histopathology.
[18] M. Mata,et al. Cells silenced for SDHB expression display characteristic features of the tumor phenotype. , 2008, Cancer research.
[19] Narasimhan P. Agaram,et al. Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors , 2008, Clinical Cancer Research.
[20] C. Stratakis,et al. Familial gastrointestinal stromal tumors and germ-line mutations. , 2007, The New England journal of medicine.
[21] E. Campo,et al. Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. , 2007, The Journal of clinical endocrinology and metabolism.
[22] E. Gottlieb,et al. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.
[23] W. Young,et al. Functioning Paraganglioma and Gastrointestinal Stromal Tumor of the Jejunum in Three Women: Syndrome or Coincidence , 2006, The American journal of surgical pathology.
[24] H. Prokisch,et al. Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA) , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[25] L. Sobin,et al. Gastrointestinal Stromal Tumors of the Stomach in Children and Young Adults: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 44 Cases With Long-Term Follow-Up and Review of the Literature , 2005, The American journal of surgical pathology.
[26] J R Griffiths,et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.
[27] Sandro Santagata,et al. A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas , 2005, PLoS genetics.
[28] N. Socci,et al. Gastrointestinal Stromal Tumors in Children and Young Adults: A Clinicopathologic, Molecular, and Genomic Study of 15 Cases and Review of the Literature , 2005, Journal of pediatric hematology/oncology.
[29] L. Sobin,et al. Gastrointestinal Stromal Tumors of the Stomach: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 1765 Cases With Long-term Follow-up , 2005, The American journal of surgical pathology.
[30] S. Hirota,et al. Absence of c‐kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients , 2004, The Journal of pathology.
[31] Samuel Singer,et al. PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors , 2003, Science.
[32] L. Sobin,et al. Gastrointestinal Glomus Tumors: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 32 Cases , 2002, The American journal of surgical pathology.
[33] P. Rustin,et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. , 2001, American journal of human genetics.
[34] S. Hirota,et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. , 1998, Science.
[35] M. O'sullivan,et al. SDHB immunohistochemistry: a useful tool in the diagnosis of Carney–Stratakis and Carney triad gastrointestinal stromal tumors , 2011, Modern Pathology.
[36] Jean-Yves Scoazec,et al. BRAF mutation status in gastrointestinal stromal tumors. , 2010, American journal of clinical pathology.
[37] J. Ellison,et al. Clinical and molecular genetics of patients with the Carney–Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD , 2008, European Journal of Human Genetics.
[38] L. Aaltonen,et al. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. , 2004, American journal of human genetics.